Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
50,3 PLN | -0,98% | -6,17% | -12,70% |
Vakgebied
Verkoop per activiteit
PLN in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Novel Small Molecule Therapies
100,0
%
| 39 | 100,0 % | 47 | 100,0 % | +20,32% |
Verkoop per regio
PLN in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
European Union Countries
88,9
%
| 25 | 63,2 % | 42 | 88,9 % | +69,25% |
Other Countries
11,0
%
| 14 | 36,5 % | 5 | 11,0 % | -63,73% |
Poland
0,1
%
| 0 | 0,3 % | 0 | 0,1 % | -64,15% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-01-07 | |
Hendrik Nogai
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-22 |
Chief Operating Officer | 38 | 01-01-13 | |
Chief Tech/Sci/R&D Officer | - | 01-01-07 | |
Vatnak Vat-Ho
PRN | Corporate Officer/Principal | - | 26-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | - | |
Scott Fields
BRD | Director/Board Member | 69 | 14-06-23 |
Thomas Turalski
BRD | Director/Board Member | - | - |
Rafal Chwast
BRD | Director/Board Member | - | - |
Piotr Romanowski
CHM | Chairman | - | 01-01-19 |
Director/Board Member | 64 | 01-10-19 | |
Peter Smith
BRD | Director/Board Member | - | 14-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 23 120 148 | 14 971 356 ( 64,75 %) | 8 ( 0,000035 %) | 64,75 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,70% | 292 mln. | |
-0,49% | 105 mld. | |
+3,31% | 97,5 mld. | |
+2,77% | 22,19 mld. | |
-16,16% | 21,33 mld. | |
-7,38% | 18,68 mld. | |
-41,41% | 16,6 mld. | |
-22,87% | 14,52 mld. | |
+6,32% | 14,09 mld. | |
+21,46% | 10,99 mld. |